GIANVI
Live / Registered — Registered and renewed (as of 21 Oct 2020)
What this means for you
Registered since 14 Sept 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 Sept 2020).
Record
- Serial number
- 77424782
- Registration number
- 3848246
- Mark type
- Stylized text
- Filed
- 18 Mar 2008
- Published for opposition
- 24 Jun 2008
- Registered
- 14 Sept 2010
- Next maintenance due
- 14 Sept 2020
- Attorney of record
- Lori Wolfe
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention of pregnancy
Owner
- Teva Pharmaceuticals USA, Inc., Parsippany, NJ, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
Prosecution history
- 18 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Oct 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 Oct 2020 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 21 Oct 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 16 Oct 2020 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 15 Oct 2020 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 14 Oct 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Aug 2020 — TEAS SECTION 8 & 9 RECEIVED
- 14 Sept 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 29 Oct 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 29 Oct 2016 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Oct 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Aug 2016 — TEAS SECTION 8 & 15 RECEIVED